Sara Tucci Selected Research

VLCAD deficiency

3/2022	Very long-chain acyl-CoA dehydrogenase deficiency in a Swedish cohort: Clinical symptoms, newborn screening, enzyme activity, and genetics.
4/2021	Altered Metabolic Flexibility in Inherited Metabolic Diseases of Mitochondrial Fatty Acid Metabolism.
1/2020	Accumulation of long-chain fatty acids in the tumor microenvironment drives dysfunction in intrapancreatic CD8+ T cells.
1/2020	Sex-specific perturbation of complex lipids in response to medium-chain fatty acids in very long-chain acyl-CoA dehydrogenase deficiency.
11/2019	The fate of medium-chain fatty acids in very long-chain acyl‑CoA dehydrogenase deficiency (VLCADD): A matter of sex?
11/2018	The diagnostic challenge in very-long chain acyl-CoA dehydrogenase deficiency (VLCADD).
1/2017	Very long-chain acyl-CoA dehydrogenase (VLCAD-) deficiency-studies on treatment effects and long-term outcomes in mouse models.
11/2015	De novo fatty acid biosynthesis and elongation in very long-chain acyl-CoA dehydrogenase-deficient mice supplemented with odd or even medium-chain fatty acids.
7/2015	Sexual dimorphism of lipid metabolism in very long-chain acyl-CoA dehydrogenase deficient (VLCAD-/-) mice in response to medium-chain triglycerides (MCT).
12/2014	Renal response to short- and long-term exercise in very-long-chain acyl-CoA dehydrogenase-deficient (VLCAD(-/-)) mice.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sara Tucci Research Topics

Disease

15	VLCAD deficiency 03/2022 - 09/2010
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 08/2011
3	Metabolic Diseases (Metabolic Disease) 06/2022 - 01/2020
3	Cardiomyopathies (Cardiomyopathy) 10/2020 - 08/2011
2	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2022 - 01/2020
2	Trifunctional Protein Deficiency With Myopathy And Neuropathy 01/2021 - 01/2021
2	Muscular Diseases (Myopathy) 10/2020 - 08/2011
2	Insulin Resistance 01/2017 - 07/2015
2	Dyslipidemias (Dyslipidemia) 07/2015 - 05/2013
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 06/2022
1	Coma (Comas) 06/2022
1	Alzheimer Disease (Alzheimer's Disease) 06/2022
1	Parkinson Disease (Parkinson's Disease) 06/2022
1	Medium chain acyl CoA dehydrogenase deficiency 01/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2021
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 10/2020
1	Epilepsy (Aura) 01/2020
1	Adenocarcinoma 01/2020
1	Neoplasms (Cancer) 01/2020
1	Homocystinuria 10/2017
1	Hyperlipidemias (Hyperlipidemia) 01/2017
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2017
1	Fatty Liver 07/2015
1	Renal Insufficiency (Renal Failure) 12/2014
1	Body Weight (Weight, Body) 05/2013
1	Non-alcoholic Fatty Liver Disease 08/2011
1	Hepatomegaly 11/2010

Drug/Important Bio-Agent (IBA)

15	Fatty Acids (Saturated Fatty Acids)IBA 06/2022 - 09/2010
12	Long-Chain Acyl-CoA Dehydrogenase (Long-Chain-Acyl-Coenzyme A Dehydrogenase)IBA 01/2020 - 11/2010
6	Triglycerides (Triacylglycerol)IBA 01/2017 - 09/2010
4	LipidsIBA 06/2022 - 05/2013
3	EnzymesIBA 03/2022 - 11/2018
2	Mitochondrial Trifunctional ProteinIBA 06/2022 - 01/2021
2	Palmitoyl Coenzyme A (Palmitoyl CoA)IBA 03/2022 - 12/2014
1	Coenzyme A Ligases (Acid-Thiol Ligases)IBA 04/2021
1	malonyl-CoA synthetaseIBA 04/2021
1	SphingomyelinsIBA 01/2021
1	Acyl-CoA Dehydrogenase (Medium-Chain Acyl-Coenzyme A Dehydrogenase)IBA 01/2021
1	CeramidesIBA 01/2021
1	Systemic carnitine deficiencyIBA 10/2020
1	Carnitine (L-Carnitine)FDA LinkGeneric 10/2020
1	triheptanoinIBA 01/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	PPAR gammaIBA 01/2020
1	stearoyl-coenzyme A (stearoyl-CoA)IBA 10/2017
1	Sulfur Amino AcidsIBA 10/2017
1	LeptinIBA 10/2017
1	GlycogenIBA 12/2014
1	Nonesterified Fatty Acids (NEFA)IBA 05/2013
1	Dietary Fats (Dietary Fat)IBA 04/2013
1	CarbohydratesIBA 04/2013

Therapy/Procedure

1	Therapeutics 01/2021
1	Immunotherapy 01/2020